Literature DB >> 26224573

Predicting erectile dysfunction in sexually active patients seeking prostate health screening: proposal for a multivariable risk stratification.

V Favilla1, G I Russo1, G Reale1, S Leone1, T Castelli1, S La Vignera2, R A Condorelli2, A E Calogero2, S Cimino1, G Morgia1.   

Abstract

To address the severity of erectile dysfunction (ED) in consecutive sexually active men seeking a prostate health screening through a multivariable risk stratification including comorbidities and lower urinary tract symptoms (LUTS). Four hundred and twenty five consecutive subjects with stable sexual relationship with normal testosterone levels were enrolled. The International Index of Erectile Function (IIEF-5) and the International Prostate Symptom Score (IPSS) questionnaires were collected and health-significant comorbidities were scored with the Charlson comorbidity index (CCI). All the independent predictors of ED were combined to form four different risk categories of ED: low (age⩽65 years and IPSS<8 and CCI=0), intermediate (one of the following: age>65 years, IPSS⩾8 or CCI⩾1), high (two of the following: age>65 years, IPSS⩾8 or CCI⩾1) and very high (age >65 years, IPSS⩾8 and CCI⩾1). The prevalence of ED increased with increase of CCI (χ(2) likelihood ratio: 40.85, P=0.001). The median of the IIEF-5 significantly reduced with the increase of the CCI (P<0.001) and with the worsening of our risk group stratification (P<0.001). At univariate logistic regression analysis very high risk was significantly associated with of ED (odds ratio: 26.85, P<0.001). Very high-risk group predicted ED with 88% and 56% of specificity and sensitivity, respectively. Combining these risk factors through our risk stratification may be usefulness in revealing an underling ED.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26224573     DOI: 10.1038/ijir.2015.15

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  31 in total

1.  One patient out of four with newly diagnosed erectile dysfunction is a young man--worrisome picture from the everyday clinical practice.

Authors:  Paolo Capogrosso; Michele Colicchia; Eugenio Ventimiglia; Giulia Castagna; Maria Chiara Clementi; Nazareno Suardi; Fabio Castiglione; Alberto Briganti; Francesco Cantiello; Rocco Damiano; Francesco Montorsi; Andrea Salonia
Journal:  J Sex Med       Date:  2013-05-07       Impact factor: 3.802

2.  Cardiovascular aspects of sexual medicine.

Authors:  Graham Jackson; Piero Montorsi; Michael A Adams; Tarek Anis; Ahmed El-Sakka; Martin Miner; Charalambos Vlachopoulos; Edward Kim
Journal:  J Sex Med       Date:  2010-04       Impact factor: 3.802

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study.

Authors:  Giorgio Ivan Russo; Sebastiano Cimino; Eugenia Fragalà; Salvatore Privitera; Sandro La Vignera; Rosita Condorelli; Aldo E Calogero; Mario Chisari; Tommaso Castelli; Vincenzo Favilla; Giuseppe Morgia
Journal:  World J Urol       Date:  2014-09-05       Impact factor: 4.226

Review 5.  Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient.

Authors:  Piero Montorsi; Paolo M Ravagnani; Stefano Galli; Andrea Salonia; Alberto Briganti; José P Werba; Francesco Montorsi
Journal:  Eur Urol       Date:  2006-07-28       Impact factor: 20.096

Review 6.  Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.

Authors:  Raymond C Rosen
Journal:  Curr Opin Urol       Date:  2006-01       Impact factor: 2.309

Review 7.  Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.

Authors:  Franklin C Lowe
Journal:  BJU Int       Date:  2005-06       Impact factor: 5.588

8.  Sexual dysfunction in the United States: prevalence and predictors.

Authors:  E O Laumann; A Paik; R C Rosen
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

9.  Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a cross-sectional study.

Authors:  Giorgio Ivan Russo; Sebastiano Cimino; Eugenia Fragalà; Salvatore Privitera; Sandro La Vignera; Rosita Condorelli; Aldo E Calogero; Tommaso Castelli; Vincenzo Favilla; Giuseppe Morgia
Journal:  J Sex Med       Date:  2014-05-19       Impact factor: 3.802

10.  Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis.

Authors:  M Kirby; C Chapple; G Jackson; I Eardley; D Edwards; G Hackett; D Ralph; J Rees; M Speakman; J Spinks; K Wylie
Journal:  Int J Clin Pract       Date:  2013-04-25       Impact factor: 2.503

View more
  1 in total

1.  Effect of tadalafil combined with atorvastatin on hemodynamics and sexual function in middle-aged and elderly patients with hyperlipidemia complicated with erectile dysfunction.

Authors:  Lei Du; Jiang-Hua Jia; Wen-Yong Xue; Jin-Chun Qi
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.